|Title:|| Treating myocardial infarction by administration of a thrombolytic agent together with adenosine|
|Abstract:||This invention is concerned with the use of adenosine as an agent for the treatment of human beings. More particularly, this invention is concerned with the administration of adenosine to human patients by continuous intravenous infusion for, inter alia, control of blood pressure, use as a selective vasodilator, decreasing pulmonary vascular resistance, treating acute pulmonary hypertension in conjunction with idiopathic respiratory distress syndrome, in diagnosing pulmonary hypertension in conjunction with cardiac septum defects, in percutaneous transluminal angioplasty (PTCA), in coronary thrombolysis (CTL) and in radionucleide scintography.|
|Inventor(s):|| Sollevi; Alf (Bromma, SE) |
|Assignee:|| Item Development (Stocksund, SE) |
|Filing Date:||Dec 21, 1994|
|Claims:||1. In a method for coronary thrombolysis (CTL), treatment of acute myocardial infarction in a human patient by administration of thrombolytic substance having an ability to dissolve a blood clot in the coronary circulation, the improvement of simultaneously administering adenosine by continuous infusion into the blood stream of said patient to lessen negative effects of said CTL. |
2. A method as claimed in claim 1 wherein adenosine is administered intravenously at a rate of 10-100 micrograms of adenosine per kilogram bodyweight per minute.
3. A method as claimed in claim 1 wherein adenosine is administered directly into the coronary circulation at a rate of 5-30 microgram of adenosine per kilogram bodyweight per minute.
4. A method as claimed in claim 1 wherein adenosine is administered in admixture with the thrombolytic agent.
5. A solution for intravascular administration in treatment of acute myocardial infarction in a human patient, said solution comprising an effective amount of a thrombolytic substance having an ability to dissolve a blood clot in the coronary circulation and adenosine in an amount effective to prevent re-occlusion of initially occluded vessels.